UBS AM’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $12.7M | Buy |
|
|||||
|
2025
Q1 | $2.13M | Sell |
|
|||||
|
2024
Q4 | $7.52M | Buy |
|
|||||
|
2024
Q3 | $6.4M | Buy |
|
|||||
|
2024
Q2 | $6.33M | Buy |
|
|||||
|
2024
Q1 | $3.34M | Hold |
|
|||||
|
2023
Q4 | $3.57M | Buy |
|
|||||
|
2023
Q3 | $2.35M | Buy |
|
|||||
|
2023
Q2 | $1.9M | Hold |
|
|||||
|
2023
Q1 | $1.9M | Buy |
|
|||||
|
2022
Q4 | $1.54M | Buy |
|
|||||
|
2022
Q3 | $1.39M | Buy |
|
|||||
|
2022
Q2 | $819K | Sell |
|
|||||
|
2022
Q1 | $882K | Buy |
|
|||||
|
2021
Q4 | $877K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $5.94M | Sell |
|
|||||
|
2021
Q1 | $5.99M | Sell |
|
|||||
|
2020
Q4 | $5.2M | Sell |
|
|||||
|
2020
Q3 | $4.08M | Buy |
|
|||||
|
2020
Q2 | $4.57M | Buy |
|